Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03233204
Title	Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	neuroblastoma childhood osteosarcoma childhood ependymoma non-Hodgkin lymphoma Advanced Solid Tumor Ewing sarcoma hepatoblastoma rhabdomyosarcoma histiocytosis childhood medulloblastoma high grade glioma
Therapies	Olaparib
Age Groups:	adult \| child
Covered Countries	USA